Godrej Agrovet Reports Q1 FY27 Results; Highlights Resilience Amid Market Headwinds

Godrej Agrovet Reports Q1 FY27 Results; Highlights Resilience Amid Market Headwinds​

Godrej Agrovet Limited (GAVL) today announced its consolidated and standalone unaudited financial results for the first quarter of fiscal year 2027, ending June 30, 2026. The company reported a resilient performance in a challenging market environment characterized by geopolitical tensions and delays in monsoon conditions.

Q1 FY27 Financial Overview​

Consolidated sales for Godrej Agrovet Limited stood at Rs. 2,852 crore in the first quarter of FY27, marking an increase from Rs. 2,603 crore in the corresponding period of FY26. Profit before tax (PBT), excluding non-recurring items and the share of profit from Joint Venture, was reported at Rs. 172 crore for Q1 FY27, down from Rs. 188 crore in Q1 FY26.

Management Perspective​

Commenting on the quarterly results, Mr. Sunil Kataria, Chief Executive Officer and Managing Director of Godrej Agrovet Limited, stated that the company delivered a resilient performance during Q1 FY27. Despite operating under inflationary pressures and delayed monsoon conditions, consolidated sales showed double-digit growth. While profitability was impacted by temporary cost headwinds in certain businesses, management expressed confidence in navigating these challenges through operational excellence and focused cost management.

Mr. Kataria noted that the quarter saw robust volume-led growth across most businesses. The Animal Nutrition segment delivered strong revenue momentum due to improved realizations and disciplined execution relating to sourcing and operating leverage. Furthermore, the Bangladesh joint venture, ACI Godrej Agrovet, returned to a solid growth path, achieving healthy volume and profitability growth.

Segment Performance Highlights​

Animal Nutrition​

The Animal Nutrition business recorded robust topline growth, driven by strong demand-led volume expansion and improved realizations. Cattle feed volumes grew by approximately 15% year-over-year (YoY), reinforcing the segment's market leadership. Underlying segment results strengthened materially, improving by about 36% YoY, attributed to strategic commodity sourcing, operating leverage, and rigorous cost discipline.

Oil Palm​

The Oil Palm segment saw revenue growth, supported by improved realizations and higher sales volumes. Fresh Fruit Bunch (FFB) volumes remained broad flat despite a high comparable base in Q1 FY26, which had benefited from the early monsoon onset. Segment results increased YoY due to enhanced oil extraction efficiency and better realizations.

Crop Care​

Demand in the Crop Care business was muted owing to the delayed monsoon progression and slower kharif sowings, particularly following one of the driest June in over a decade. This resulted in a de-growth in segment revenue primarily because of lower volumes of the in-house cotton herbicide. Despite this pressure on margins, the company's innovation portfolio diversification efforts continued gaining traction. New launches such as Ashitaka (Maize Herbicide) and Takai (Paddy insecticide) showed strong market traction, helping partially mitigate the adverse impact of market conditions during the quarter.

Astec LifeSciences​

Astec LifeSciences sustained its recovery momentum in Q1 FY27, reporting a substantial improvement in EBITDA compared to Q1 FY26. This turnaround achievement was driven by margin expansion across both Enterprise and CDMO categories, positioning the business for sustained profitability and growth following the operational improvements achieved in FY26. Revenue saw a marginal de-growth due to changes in product mix.

Dairy​

The Dairy business delivered healthy revenue growth compared to Q1 FY26, driven by strong volume growth in value-added products. The salience of these value-added products increased from 42% in Q1 FY26 to 49% in Q1 FY27. However, profitability was impacted by industry-wide milk inflation and war-related inflation affecting some inputs. Management is focused on cost optimization and calibrated pricing actions to mitigate short-term pressures.

Godrej Foods Limited (GFL)​

Branded volume salience grew approximately 6% YoY in Q1 FY27, which helped offset the impact of deliberate reductions in live bird volumes, allowing GFL to achieve stable revenues while improving earnings quality. EBITDA margins moderated due to higher input costs and inflationary pressure stemming from geopolitical disruptions, despite calibrated pricing actions by the company.

ACI Godrej Agrovet Private Limited, Bangladesh​

The Bangladeshi operation showed a strong recovery, returning firmly to a growth trajectory with robust topline growth driven primarily by broad-based volume expansion across categories. PBT increased YoY by 12%, propelled by operational leverage and volume growth. Profit after tax saw a decline YoY due to the impact of a higher effective tax rate following the change in the applicable tax rate from 15% to 27.5% effective July 1, 2025.

Strategic Focus​

The company noted that the significant improvement in net working capital over the past two years reflects a disciplined focus on cash generation and value creation. As Godrej Agrovet progresses through FY27, it remains focused on building a customer and market centric organization with sharp execution focus to build a stronger, higher return portfolio.

GODREJAGRO Stock Price Movement​

Today, Godrej Agrovet Limited shares edged higher, settling at ₹566.45 after gaining 0.50%. The stock saw a trading volume of 80,487 shares during the session.